Funding for this research was provided by:
Cancer Research UK (A27412 and A22902)
Article History
Received: 5 February 2021
Revised: 26 February 2021
Accepted: 2 March 2021
First Online: 6 April 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: R.M. consultants for Pfizer, and as a former Institute of Cancer Research (London) employee, he may benefit from commercialised programmes. The other authors declare no competing interests.
: We are grateful for funding from Cancer Research UK (A27412 and A22902), the Wellcome Trust (100282/Z/12/Z), the European Research Council (ERC-ADG-2014 671262) and the European Commission under the Horizon 2020 programme (U.M. Cure; project 667787).